Human metapneumovirus establishes persistent infection in the lungs of mice and is reactivated by glucocorticoid treatment

Journal of Virology

Volumn 83, Issue 13, 2009, Pages 6837-6848

  Liu, Yuru ^a   Haas, Debra L ^a   Poore, Spencer ^a   Isakovic, Sanjin ^a   Gahan, Michelle ^b   Mahalingam, Suresh ^b   Fu, Zhen F ^a   Tripp, Ralph A ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF CANBERRA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHIOLITIS; CHRONICITY; FEMALE; GENOTYPE; HUMAN METAPNEUMOVIRUS; IMMUNOHISTOCHEMISTRY; LUNG INFECTION; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REINFECTION; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS REPLICATION; WHEEZING; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DISEASE MODEL; EPITHELIUM CELL; LUNG; METAPNEUMOVIRUS; NERVE FIBER; PATHOGENICITY; PATHOLOGY; VIROLOGY; VIRUS ACTIVATION;

HUMAN METAPNEUMOVIRUS; MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; GLUCOCORTICOIDS; LUNG; METAPNEUMOVIRUS; MICE; MICE, INBRED BALB C; NERVE FIBERS; PARAMYXOVIRIDAE INFECTIONS; VIRUS ACTIVATION;

EID: 67449083079     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00379-09     Document Type: Article

References (80)

1. Alvarez, R., K. S. Harrod, W. J. Shieh, S. Zaki, and R. A. Tripp. 2004. Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies. J. Virol. 78:14003-14011. (Pubitemid 39612796)
2. Alvarez, R., and R. A. Tripp. 2005. The immune response to human meta-pneumovirus is associated with aberrant immunity and impaired virus clearance in BALB/c mice. J. Virol. 79:5971-5978. (Pubitemid 40617203)
3. Bagasra, O. 2007. Protocols for the in situ PCR-amplification and detection of mRNA and DNA sequences. Nat. Protocols 2:2782-2795.
4. Bao, X., T. Liu, Y. Shan, K. Li, R. P. Garofalo, and A. Casola. 2008. Human metapneumovirus glycoprotein G inhibits innate immune responses. PLoS Pathog. 4:e1000077. (Pubitemid 351811514)
5. Bastien, N., S. Normand, T. Taylor, D. Ward, T. C. Peret, G. Boivin, L. J. Anderson, and Y. Li. 2003. Sequence analysis of the N, P, M, and F genes of Canadian human metapneumovirus strains. Virus Res. 93:51-62.
6. Beckham, J. D., A. Cadena, J. Lin, P. A. Piedra, W. P. Glezen, S. B. Greenberg, and R. L. Atmar. 2005. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J. Infect. 50:322-330. (Pubitemid 40533369)
7. Biacchesi, S., M. H. Skiadopoulos, G. Boivin, C. T. Hanson, B. R. Murphy, P. L. Collins, and U. J. Buchholz. 2003. Genetic diversity between human metapneumovirus subgroups. Virology 315:1-9. (Pubitemid 37340045)
8. Biacchesi, S., M. H. Skiadopoulos, L. Yang, E. W. Lamirande, K. C. Tran, B. R. Murphy, P. L. Collins, and U. J. Buchholz. 2004. Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J. Virol. 78:12877-12887. (Pubitemid 39507796)
9. Bossert, B., S. Marozin, and K. K. Conzelmann. 2003. Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J. Virol. 77:8661-8668. (Pubitemid 36936076)
10. Bramley, A. M., T. Z. Vitalis, B. R. Wiggs, and R. G. Hegele. 1999. Effects of respiratory syncytial virus persistence on airway responsiveness and inflammation in guinea pigs. Eur. Respir. J. 14:1061-1067.
11. Buchholz, U. J., K. Nagashima, B. R. Murphy, and P. L. Collins. 2006. Live vaccines for human metapneumovirus designed by reverse genetics. Expert Rev. Vaccines 5:695-706. (Pubitemid 46021050)
12. Camargo, C. A., Jr., A. A. Ginde, S. Clark, C. P. Cartwright, A. R. Falsey, and D. E. Niewoehner. 2008. Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease. Intern. Emerg. Med. 3:355-359.
13. Cane, P. A., and C. R. Pringle. 1995. Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein. J. Virol. 69:2918-2925.
14. Cole, T. J. 2006. Glucocorticoid action and the development of selective glucocorticoid receptor ligands. Biotechnol. Annu. Rev. 12:269-300.
15. Crowe, J. E., Jr. 2004. Human metapneumovirus as a major cause of human respiratory tract disease. Pediatr. Infect. Dis. J. 23:S215-S221.
16. Cseke, G., M. S. Maginnis, R. G. Cox, S. J. Tollefson, A. B. Podsiad, D. W. Wright, T. S. Dermody, and J. V. Williams. 2009. Integrin alphavbeta1 promotes infection by human metapneumovirus. Proc. Natl. Acad. Sci. USA 106:1566-1571.
17. Dakhama, A., T. Z. Vitalis, and R. G. Hegele. 1997. Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis. Eur. Respir. J. 10:20-26.
18. Darniot, M., C. Pitoiset, T. Petrella, S. Aho, P. Pothier, and C. Manoha. 2009. Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice. J. Virol. 83:3323-3332.
19. Day, I. N. 1992. Enolases and PGP9.5 as tissue-specific markers. Biochem. Soc. Trans. 20:637-642.
20. Debiaggi, M., F. Canducci, M. Sampaolo, M. C. Marinozzi, M. Parea, C. Terulla, A. A. Colombo, E. P. Alessandrino, L. Z. Bragotti, M. Arghittu, A. Goglio, R. Migliavacca, E. Romero, and M. Clementi. 2006. Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. J. Infect. Dis. 194:474-478.
21. Dinwiddie, D. L., and K. S. Harrod. 2008. Human metapneumovirus inhibits IFN-alpha signaling through inhibition of STAT1 phosphorylation. Am. J. Respir. Cell Mol. Biol. 38:661-670.
22. Englund, J. A., M. Boeckh, J. Kuypers, W. G. Nichols, R. C. Hackman, R. A. Morrow, D. N. Fredricks, and L. Corey. 2006. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann. Intern. Med. 144:344-349.
23. Estripeaut, D., J. P. Torres, C. S. Somers, C. Tagliabue, S. Khokhar, V. G. Bhoj, S. M. Grube, A. Wozniakowski, A. M. Gomez, O. Ramilo, H. S. Jafri, and A. Mejias. 2008. Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model. J. Infect. Dis. 198:1435-1443.
24. Falsey, A. R. 2008. Human metapneumovirus infection in adults. Pediatr. Infect. Dis. J. 27:S80-S83.
25. Falsey, A. R., M. A. Formica, P. A. Hennessey, M. M. Criddle, W. M. Sullender, and E. E. Walsh. 2006. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 173:639-643.
26. Falsey, A. R., and E. E. Walsh. 2006. Viral pneumonia in older adults. Clin. Infect. Dis. 42:518-524.
27. Fontana, J. M., B. Bankamp, and P. A. Rota. 2008. Inhibition of interferon induction and signaling by paramyxoviruses. Immunol. Rev. 225:46-67.
28. Fuentes, S., K. C. Tran, P. Luthra, M. N. Teng, and B. He. 2007. Function of the respiratory syncytial virus small hydrophobic protein. J. Virol. 81:8361-8366.
29. Gotoh, B., T. Komatsu, K. Takeuchi, and J. Yokoo. 2001. Paramyxovirus accessory proteins as interferon antagonists. Microbiol. Immunol. 45:787-800.
30. Groskreutz, D. J., M. M. Monick, T. O. Yarovinsky, L. S. Powers, D. E. Quelle, S. M. Varga, D. C. Look, and G. W. Hunninghake. 2007. Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells. J. Immunol. 179:2741-2747.
31. Halford, W. P., B. W. Gebhardt, and D. J. Carr. 1996. Mechanisms of herpes simplex virus type 1 reactivation. J. Virol. 70:5051-5060. (Pubitemid 26240675)
32. Hamelin, M. E., G. A. Prince, A. M. Gomez, R. Kinkead, and G. Boivin. 2006. Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice. J. Infect. Dis. 193:1634-1642.
33. Hanania, N. A. 2008. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Pulm. Pharmacol. Ther. 21:540-550.
34. + T-cell responses. J. Immunol. 176:1600-1608.
35. Harrod, K. S., R. J. Jaramillo, C. L. Rosenberger, S. Z. Wang, J. A. Berger, J. D. McDonald, and M. D. Reed. 2003. Increased susceptibility to RSV infection by exposure to inhaled diesel engine emissions. Am. J. Respir. Cell Mol. Biol. 28:451-463.
36. Hayashida, S., K. S. Harrod, and J. A. Whitsett. 2000. Regulation and function of CCSP during pulmonary Pseudomonas aeruginosa infection in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:L452-L459.
37. Hegele, R. G., S. Hayashi, A. M. Bramley, and J. C. Hogg. 1994. Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea pigs. Chest 105:1848-1854. (Pubitemid 24180681)
38. Kahn, J. S. 2006. Epidemiology of human metapneumovirus. Clin. Microbiol. Rev. 19:546-557.
39. Kolli, D., E. L. Bataki, L. Spetch, A. Guerrero-Plata, A. M. Jewell, P. A. Piedra, G. N. Milligan, R. P. Garofalo, and A. Casola. 2008. T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J. Virol. 82:8560-8569.
40. Komatsu, T., K. Takeuchi, and B. Gotoh. 2007. Bovine parainfluenza virus type 3 accessory proteins that suppress beta interferon production. Microbes Infect. 9:954-962. (Pubitemid 46924839)
41. Kraus, T. A., L. Garza, and C. M. Horvath. 2008. Enabled interferon signaling evasion in an immune-competent transgenic mouse model of parainfluenza virus 5 infection. Virology 371:196-205.
42. Kuiken, T., B. G. van den Hoogen, D. A. van Riel, J. D. Laman, G. van Amerongen, L. Sprong, R. A. Fouchier, and A. D. Osterhaus. 2004. Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am. J. Pathol. 164:1893-1900.
43. Li, X. Q., Z. F. Fu, R. Alvarez, C. Henderson, and R. A. Tripp. 2006. Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein. J. Virol. 80:537-540.
44. Lo, M. S., R. M. Brazas, and M. J. Holtzman. 2005. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 79:9315-9319. (Pubitemid 40934843)
45. Mahalingam, S., J. Schwarze, A. Zaid, M. Nissen, T. Sloots, S. Tauro, J. Storer, R. Alvarez, and R. A. Tripp. 2006. Perspective on the host response to human metapneumovirus infection: what can we learn from respiratory syncytial virus infections? Microbes Infect. 8:285-293.
46. Manoha, C., S. Espinosa, S. L. Aho, F. Huet, and P. Pothier. 2007. Epidemiological and clinical features of hMPV, RSV and RVs infections in young children. J. Clin. Virol. 38:221-226.
47. Martin, J. G., S. Siddiqui, and M. Hassan. 2006. Immune responses to viral infections: relevance for asthma. Paediatr. Respir. Rev. 7(Suppl. 1):S125-S127.
48. Martinello, R. A., F. Esper, C. Weibel, D. Ferguson, M. L. Landry, and J. S. Kahn. 2006. Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J. Infect. 53:248-254. (Pubitemid 44391059)
49. Mazzoncini, J. P., Jr., C. B. Crowell, and C. S. Kang. 2008. Human metapneumovirus: an emerging respiratory pathogen. J. Emerg. Med.
50. McCullough, K. C. 1983. Characterization of a non-syncytiogenic autonomously replicating variant of measles virus. J. Gen. Virol. 64(Pt. 3):749-754.
51. McManus, T. E., A. M. Marley, N. Baxter, S. N. Christie, H. J. O'Neill, J. S. Elborn, P. V. Coyle, and J. C. Kidney. 2008. Respiratory viral infection in exacerbations of COPD. Respir. Med. 102:1575-1580.
52. Mejias, A., S. Chavez-Bueno, A. M. Gomez, C. Somers, D. Estripeaut, J. P. Torres, H. S. Jafri, and O. Ramilo. 2008. Respiratory syncytial virus persistence: evidence in the mouse model. Pediatr. Infect. Dis. J. 27:S60-S62.
53. Moore, E. C., J. Barber, and R. A. Tripp. 2008. Respiratory syncytial virus (RSV) attachment and nonstructural proteins modify the type I interferon response associated with suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 (ISG15). Virol. J. 5:116.
54. Mullins, J. A., D. D. Erdman, G. A. Weinberg, K. Edwards, C. B. Hall, F. J. Walker, M. Iwane, and L. J. Anderson. 2004. Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg. Infect. Dis. 10:700-705.
55. Munir, S., C. Le Nouen, C. Luongo, U. J. Buchholz, P. L. Collins, and A. Bukreyev. 2008. Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells. J. Virol. 82:8780-8796.
56. Parisien, J. P., J. F. Lau, and C. M. Horvath. 2002. STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J. Virol. 76:6435-6441. (Pubitemid 34633508)
57. Rohde, G., I. Borg, U. Arinir, J. Kronsbein, R. Rausse, T. T. Bauer, A. Bufe, and G. Schultze-Werninghaus. 2005. Relevance of human metapneumovirus in exacerbations of COPD. Respir. Res. 6:150.
58. Sabine Vollstedt, M. F., G. Alber, M. Ackermann, and M. Suter. 2001. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1. J. Virol. 75:9596-9600. (Pubitemid 32900094)
59. Schowalter, R. M., S. E. Smith, and R. E. Dutch. 2006. Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J. Virol. 80:10931-10941. (Pubitemid 44706534)
60. Schwarze, J., D. R. O'Donnell, A. Rohwedder, and P. J. Openshaw. 2004. Latency and persistence of respiratory syncytial virus despite T-cell immunity. Am. J. Respir. Crit. Care Med. 169:801-805.
61. Sikkel, M. B., J. K. Quint, P. Mallia, J. A. Wedzicha, and S. L. Johnston. 2008. Respiratory syncytial virus persistence in chronic obstructive pulmonary disease. Pediatr. Infect. Dis. J. 27:S63-S70.
62. Sin, D. D., and S. F. Man. 2006. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases. Eur. J. Pharmacol. 533:28-35.
63. Skiadopoulos, M. H., S. Biacchesi, U. J. Buchholz, J. M. Riggs, S. R. Surman, E. Amaro-Carambot, J. M. McAuliffe, W. R. Elkins, M. St Claire, P. L. Collins, and B. R. Murphy. 2004. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J. Virol. 78:6927-6937. (Pubitemid 38781531)
64. Spann, K. M., K. C. Tran, B. Chi, R. L. Rabin, and P. L. Collins. 2004. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J. Virol. 78:4363-4369. (Pubitemid 38437240)
65. Tate, M. C., A. J. Garcia, B. G. Keselowsky, M. A. Schumm, D. R. Archer, and M. C. LaPlaca. 2004. Specific beta1 integrins mediate adhesion, migration, and differentiation of neural progenitors derived from the embryonic striatum. Mol. Cell Neurosci. 27:22-31.
66. Tripp, R. A. 2004. The brume surrounding respiratory syncytial virus persistence. Am. J. Respir. Crit. Care Med. 169:778-779.
67. Tripp, R. A., L. Jones, and L. J. Anderson. 2000. Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse. J. Virol. 74:6227-6229. (Pubitemid 30413000)
68. Tripp, R. A., L. P. Jones, L. M. Haynes, H. Zheng, P. M. Murphy, and L. J. Anderson. 2001. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat. Immunol. 2:732-738.
69. Tripp, R. A., D. Moore, L. Jones, W. Sullender, J. Winter, and L. J. Anderson. 1999. Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J. Virol. 73:7099-7107. (Pubitemid 29383189)
70. Tripp, R. A., D. Moore, J. Winter, and L. J. Anderson. 2000. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice. J. Virol. 74:1614-1622. (Pubitemid 30434016)
71. Tripp, R. A., C. Oshansky, and R. Alvarez. 2005. Cytokines and respiratory syncytial virus infection. Proc. Am. Thorac. Soc. 2:147-149.
72. Valdovinos, M. R., and B. Gomez. 2003. Establishment of respiratory syncytial virus persistence in cell lines: association with defective interfering particles. Intervirology 46:190-198. (Pubitemid 36928650)
73. van den Hoogen, B. G., J. C. de Jong, J. Groen, T. Kuiken, R. de Groot, R. A. Fouchier, and A. D. Osterhaus. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7:719-724.
74. van den Hoogen, B. G., S. Herfst, M. de Graaf, L. Sprong, R. van Lavieren, G. van Amerongen, S. Yuksel, R. A. Fouchier, A. D. Osterhaus, and R. L. de Swart. 2007. Experimental infection of macaques with human metapneumovirus induces transient protective immunity. J. Gen. Virol. 88:1251-1259.
75. van den Hoogen, B. G., D. M. Osterhaus, and R. A. Fouchier. 2004. Clinical impact and diagnosis of human metapneumovirus infection. Pediatr. Infect. Dis. J. 23:S25-S32.
76. Varkey, J. B., and B. Varkey. 2008. Viral infections in patients with chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 14:89-94.
77. Wilkinson, K. D., K. M. Lee, S. Deshpande, P. Duerksen-Hughes, J. M. Boss, and J. Pohl. 1989. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl- terminal hydrolase. Science 246:670-673. (Pubitemid 19283361)
78. Wilkinson, T. M., G. C. Donaldson, S. L. Johnston, P. J. Openshaw, and J. A. Wedzicha. 2006. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 173:871-876.
79. Wolf, D. G., D. Greenberg, D. Kalkstein, Y. Shemer-Avni, N. Givon-Lavi, N. Saleh, M. D. Goldberg, and R. Dagan. 2006. Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children. Pediatr. Infect. Dis. J. 25:320-324.
80. Zheng, H., G. A. Storch, C. Zang, T. C. Peret, C. S. Park, and L. J. Anderson. 1999. Genetic variability in envelope-associated protein genes of closely related group A strains of respiratory syncytial virus. Virus Res. 59:89-99. (Pubitemid 29069056)